A promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitis.
Adamus G, Karren LJ, Mooney J, Burrows GG
Ophthalmic Res. 2010; 44(1):24-33. Epub 2010 Feb 08. PMID: 20145422.Abstract